phone: +48 22 721 40 00   /  fax: +48 22 721 13 33  /


Press releases



Warsaw, 9 June 2016

Bioton to extend cooperation with MSD

BIOTON S.A. and MSD, a part of the American concern Merck & Co., have concluded an agreement according to which BIOTON shall cooperate with MSD within the scope of development of the market of hypercholesterolemia treatment with an innovative medication - Ezetrol (ezetymib).

read more




Warsaw, 26 May 2016

On 25 May 2016 the Supervisory Board of Bioton S.A. ("Bioton", "Company") decided to form a strategy development committee whose principal task will be to raise Bioton's operations to global level and to develop diabetes products portfolio, as the main area of Company operation. Therefore, the Supervisory Board has decided to delegate its Chairman, Mr Jubo Liu and a Vice Chairman, Mr Dariusz Trzeciak, to directly supervise the process of development and implementation of the new strategy of the Company.

read more



Current reports


Current report 2017/35 dated 30.10.2017, time 13.12 UTC

Warsaw, 30 October 2017

Change of the date of publication of BIOTON S.A. consolidated "extended" quarterly report for 3rd quarter of 2017

read more

Current report 34/2017 dated 02.10.2017, time 13:25 UTC

Warsaw, 2 October 2017

Resignation of a person supervising Bioton S.A.

read more

© 2017 BIOTON S.A.